-
公开(公告)号：EP3774739A1
公开(公告)日：2021-02-17
申请号：EP19785626.3
申请日：2019-04-09
申请人： RaQualia Pharma Inc. , National University Corporation Tokai National Higher Education and Research System
发明人： OHMI, Masashi , MATSUSHITA, Takeshi , ANDO, Kazuo , YAMAGUCHI, Ryuichi , FUKUMOTO, Yutaka , MAGARA, Ryohei , YAMAGISHI, Tatsuya , TAKEFUJI, Mikito
IPC分类号： C07D235/26 , A61K31/4184 , A61K31/437 , A61K31/4375 , A61K31/4439 , A61K31/4709 , A61K31/4725 , A61K31/497 , A61K31/4985 , A61K31/501 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/5377 , A61K31/5383 , A61P1/00 , A61P9/00 , A61P25/00 , A61P29/00 , A61P43/00 , C07D401/12
-
公开(公告)号：EP3116858B1
公开(公告)日：2020-11-11
申请号：EP15760744.1
申请日：2015-03-16
申请人： RaQualia Pharma Inc.
发明人： SHISHIDO, Yuji , OHMI, Masashi , ANDO, Kazuo
IPC分类号： C07D235/02 , A61K31/506 , A61K31/501 , A61K31/4985 , A61K31/498 , A61K31/497 , A61K31/4709 , A61K31/4439 , A61K31/4375 , A61K31/437 , A61K31/427 , A61K31/421 , A61K31/4166 , A61K31/4164 , A61K31/41 , A61P13/02 , A61P11/00 , A61P1/00 , A61P9/10
-
公开(公告)号：EP3676248A1
公开(公告)日：2020-07-08
申请号：EP18852154.6
申请日：2018-08-31
发明人： KAWAMURA, Kiyoshi , YAMAGISHI, Tatsuya , SHISHIDO, Yuji , MORITA, Mikio , YAMAGUCHI, Ryuichi , OHMI, Masashi
IPC分类号： C07C311/51 , A61K31/18 , A61K31/397 , A61K31/415 , A61K31/42 , A61K31/4418 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/444 , A61K31/4965 , A61K31/505 , A61K31/506 , A61K31/535 , A61P29/00 , C07D205/04 , C07D213/64 , C07D213/65 , C07D213/68 , C07D213/74
-
公开(公告)号：EP3116858A1
公开(公告)日：2017-01-18
申请号：EP15760744.1
申请日：2015-03-16
申请人： RaQualia Pharma Inc.
发明人： SHISHIDO, Yuji , OHMI, Masashi , ANDO, Kazuo
IPC分类号： C07D235/02 , A61K31/41 , A61K31/4164 , A61K31/4166 , A61K31/421 , A61K31/427 , A61K31/437 , A61K31/4375 , A61K31/4439 , A61K31/4709 , A61K31/497 , A61K31/498 , A61K31/4985 , A61K31/501 , A61K31/506 , A61P1/00 , A61P9/10 , A61P11/00 , A61P13/02
摘要： The present invention relates to azaspiro derivatives of the formula (I) or a pharmaceutically acceptable salt thereof or a prodrug thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders which are mediated via the TRPM8 receptor.
摘要翻译： 本发明涉及式（I）的氮杂螺旋衍生物或其药学上可接受的盐或其前药，其制备方法，含有它们的药物组合物以及它们在治疗通过TRPM8受体介导的各种疾病中的用途。
-
公开(公告)号：EP4222142A1
公开(公告)日：2023-08-09
申请号：EP21875780.5
申请日：2021-09-30
申请人： RaQualia Pharma Inc.
发明人： ANDO, Kazuo , OHMI, Masashi , MAGARA, Ryohei
IPC分类号： C07D209/38 , A61K31/404 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/4725 , A61K45/00 , A61P1/00 , A61P5/38 , A61P9/04 , A61P9/10 , A61P9/12 , A61P15/00 , C07D401/12
-
公开(公告)号：EP2401268B1
公开(公告)日：2015-07-29
申请号：EP10746028.9
申请日：2010-03-01
申请人： RaQualia Pharma Inc
发明人： SUDO, Masaki , IWATA, Yasuhiro , ARANO, Yoshimasa , JINNO, Madoka , OHMI, Masashi , NOGUCHI, Hirohide
IPC分类号： C07D401/14 , A61K31/454 , A61K31/497 , A61P1/04 , A61P1/06 , A61P43/00 , C07D401/04
CPC分类号： C07D401/04 , C07D401/14
-
公开(公告)号：EP2401268A1
公开(公告)日：2012-01-04
申请号：EP10746028.9
申请日：2010-03-01
申请人： RaQualia Pharma Inc
发明人： SUDO, Masaki , IWATA, Yasuhiro , ARANO, Yoshimasa , JINNO, Madoka , OHMI, Masashi , NOGUCHI, Hirohide
IPC分类号： C07D401/14 , A61K31/454 , A61K31/497 , A61P1/04 , A61P1/06 , A61P43/00 , C07D401/04
CPC分类号： C07D401/04 , C07D401/14
摘要： The present invention relates to novel oxyindole derivatives of formula (I) or a pharmaceutically acceptable salt thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders which are mediated via the motilin receptor (GPR38).
-
公开(公告)号：EP3350171A1
公开(公告)日：2018-07-25
申请号：EP16843958.6
申请日：2016-09-12
申请人： RaQualia Pharma Inc.
发明人： SHISHIDO, Yuji , OHMI, Masashi
IPC分类号： C07D235/12 , A61K31/4184 , A61K31/437 , A61K31/501 , A61P1/00 , A61P9/10 , A61P11/00 , A61P13/02 , A61P25/00 , A61P29/00 , A61P37/02 , A61P43/00 , C07D403/12 , C07D471/04
CPC分类号： C07D403/12 , A61K31/4184 , A61K31/437 , A61K31/501 , A61K45/06 , C07D403/10 , C07D471/04 , A61K2300/00
摘要： The present invention relates to imidazolinone derivatives of the formula (I) or a pharmaceutically acceptable salt thereof or a prodrug thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders which are mediated via the TRPM8 receptor.
-
公开(公告)号：EP2424517A1
公开(公告)日：2012-03-07
申请号：EP10769531.4
申请日：2010-05-06
申请人： RaQualia Pharma Inc
IPC分类号： A61K31/18 , A61K31/196 , A61K31/44 , A61K31/443 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/4453 , A61K31/4709 , A61K31/495 , A61K31/5375 , A61K31/5377 , A61P1/04 , A61P9/10 , A61P11/06 , A61P13/00 , A61P13/02 , A61P13/08 , A61P13/10 , A61P13/12
CPC分类号： C07C311/21 , A61K31/18 , A61K31/196 , A61K31/44 , A61K31/443 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/4453 , A61K31/4709 , A61K31/495 , A61K31/5375 , A61K31/5377 , A61K45/06 , C07D213/42 , C07D213/75 , C07D295/13 , C07D295/185 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/12 , C07D409/04 , C07D409/12 , C07D413/12 , C07D417/12 , A61K2300/00
摘要： The present invention relates to sulfamoyl benzoic acid derivatives of formula (I) or a pharmaceutically acceptable salt thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders which are mediated via the TRPM8 receptor.
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.019 秒)
